TAILIEUCHUNG - Esophageal Cancer – Cell and Molecular Biology, Biomarkers, Nutrition and Treatment Edited by Ferdous Rastgar Jazii Published

ider impact of our publications. After this work has been published by InTech, authors have the right to republish it, in whole or part, in any publication of which they are the author, and to make other personal use of the work. Any republication, referencing or personal use of the work must explicitly identify the original source. As for readers, this license allows users to download, copy and build upon published chapters even for commercial purposes, as long as the author and publisher are properly credited,. | ESOPHAGEAL CANCER-CELL AND MOLECULAR BIOLOGY BIOMARKERS NUTRITION AND TREATMENT Edited by Ferdous Rastgar Jazii Esophageal Cancer - Cell and Molecular Biology Biomarkers Nutrition and Treatment Edited by Ferdous Rastgar Jazii Published by InTech Janeza Trdine 9 51000 Rijeka Croatia Copyright 2012 InTech All chapters are Open Access distributed under the Creative Commons Attribution license which allows users to download copy and build upon published articles even for commercial purposes as long as the author and publisher are properly credited which ensures maximum dissemination and a wider impact of our publications. After this work has been published by InTech authors have the right to republish it in whole or part in any publication of which they are the author and to make other personal use of the work. Any republication referencing or personal use of the work must explicitly identify the original source. As for readers this license allows users to download copy and build upon published chapters even for commercial purposes as long as the author and publisher are properly credited which ensures maximum dissemination and a wider impact of our publications. Notice Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials instructions methods or ideas contained in the book. Publishing Process Manager Romana Vukelic Technical Editor Teodora Smiljanic Cover Designer InTech Design Team First published March 2012 Printed in Croatia A free online edition of this book is available at Additional hard copies can be obtained from orders@ Esophageal Cancer - Cell and Molecular Biology Biomarkers Nutrition and .

• Y học thường thức
• Esophageal
• Cancer
• Molecular
• Biology
• Health
• Sciences
• medicine
• pharmacolocy
• stro esophageal reflux disease
• Lecture Gastro esophageal reflux disease
• Gastroesophageal reflux esophagitis
• Lecture gastro esophageal reflux
• Gastroesophageal reflux symptoms
• Pathophysiology of GERD
• Medicine use in GERD
• BMC Cancer
• Esophageal fistula
• Esophageal squamous cell carcinoma
• Risk factor
• Standard treatment
• Esophageal cancer
• Esophageal adenocarcinoma
• Cox’s proportional hazards analysis
• BMC Genomics
• Molecular subtype
• Gene expression
• Esophageal carcinoma
• Esophageal squamous carcinoma
• Multivariate logistic regression analysis
• Concurrent chemoradiotherapy
• 3D conformal radiation therapy
• Non surgical esophageal cancer
• 103 Military Hospital
• Esophageal cancer patients
• Whole exome sequencing
• Fastq2vcf modified
• Generation sequencing
• 18FDG PET CT simulation
• 3D conformal radiotherapy
• CT simulation in 3D conformal
• Chemo radiotherapy for esophageal cancer
• Upper third esophageal cancer
• Intensity modulated radiation therapy
• Intensitymodulated radiation
• Lumen apposing metal stent
• Treat malignant esophageal stricture
• Require stent placement
• Improve quality of life
• Malignant esophageal stricture
• Thoracoscopic esophagectomy
• Results of thoracoscopic esophagectomy
• 103 Military Hospital 103
• Tumor suppressor candidate 3
• Overall survival
• Human malignancies
• Esophageal neoplasm
• Salvage treatment
• Optimal salvage regimen
• Thoracic esophageal squamous cell carcinoma
• Lymph node metastases
• Invasion depth
• Neoadjuvant treatment
• Esophageal cancer surgery
• Surgical procedures performed
• Squamous cell carcinoma
• Synchronous tumors
• Gastric adenocarcinoma
• Gastrointestinal stromal tumors
• Esophageal small cell carcinoma
• Digestive system
• RAS oncogene family like 6
• Several cancers
• BMC Pediatrics
• Pediatric surgery
• Gestational age
• Esophageal atresia
• Postoperative outcome
• Esophageal anastomosis
• Meta analysis
• Palliative treatment
• Inoperable esophageal cancer
• Partially covered self expanding metallic stents
• Epidermal growth factor receptor
• Metastatic esophageal cancer
• Tissue microarray
• RBM3 expression
• Cancer types
• Esophageal epithelium
• Prognostic factor
• Controlling nutritional status
• Neoadjuvant therapy
• Cyclooxygenase 2 inhibition
• Humans suggest
• Esophageal cancer risk
• Paclitaxel carboplatin
• Gastro esophageal junctional cancer
• Platinum analogue
• Tumor development
• PHLPP2 proteins